Universal Ibogaine Inc.
IBO.V
TSX
| 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.15M | -878.60K | -1.30M | -1.78M | -4.62M |
| Total Depreciation and Amortization | 247.50K | 241.60K | 232.50K | 220.60K | 216.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 391.00K | 148.50K | 309.80K | 372.90K | 2.48M |
| Change in Net Operating Assets | -35.00K | 179.40K | 144.70K | 370.30K | -221.90K |
| Cash from Operations | -551.30K | -309.00K | -615.20K | -817.90K | -2.15M |
| Capital Expenditure | -15.90K | -33.30K | -182.90K | -227.80K | -264.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | 480.40K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -15.90K | -33.30K | -182.90K | -227.80K | 215.90K |
| Total Debt Issued | -53.70K | 326.30K | 523.30K | 523.30K | 577.00K |
| Total Debt Repaid | -131.90K | -103.30K | -88.30K | -71.90K | -165.20K |
| Issuance of Common Stock | 1.41M | 417.20K | 100.00K | 539.50K | 539.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -337.20K | -3.20K | -- | -- | 0.00 |
| Cash from Financing | 653.80K | 470.00K | 394.60K | 738.10K | 705.10K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 86.70K | 127.80K | -403.30K | -307.30K | -1.23M |
